The mutational pattern of homologous recombination (HR)-associated genes and its relevance to the immunotherapeutic response in gastric cancer
Objective: Currently, there is an urgent need to identify immunotherapeutic biomarkers to increase the benefit of immune checkpoint inhibitors (ICIs) for patients with gastric cancer (GC). Homologous recombination deficiency (HRD) can modify the tumor immune microenvironment by increasing the presen...
Main Authors: | Yue Fan, Haifeng Ying, Xueying Wu, Huan Chen, Ying Hu, Henghui Zhang, Lijia Wu, Ying Yang, Beibei Mao, Lan Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2020-11-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/1697 |
Similar Items
-
Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology
by: Alexander M. A. van der Wiel, et al.
Published: (2022-08-01) -
Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer
by: Xin Wu, et al.
Published: (2022-11-01) -
Homologous recombination proficiency in ovarian and breast cancer patients
by: Justin Fortune Creeden, et al.
Published: (2021-10-01) -
Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer
by: Jeffrey A. How, et al.
Published: (2021-02-01) -
Mutational landscape of homologous recombination‐related genes in small‐cell lung cancer
by: Shuo Wu, et al.
Published: (2023-02-01)